HEALTHCARE cost-effective drugs . The unique combination of expertise in large , antibody-based molecules and small , chemically-derived molecules places UCB in a strong position to realise this ambition . Cimzia ®, UCB ’ s New Biological Entity ( NBE ), targeted at Crohn ’ s disease and rheumatoid arthritis , is one of the first fruits of this synergy of biology and chemistry .
Connecting people : In a knowledge- and ideas-based industry like UCB ’ s , human capital is the lifeblood of success . To unlock the creative potential of our global team of 8,700 staff and their
partners , the Company is creating a networked , cross-functional organisation . Multi-disciplinary teams are working on all development projects , including members of R & D , supply chain and sales , as well as partners and patients .
UCB People , an innovative intranet tool , links the Company ’ s knowledge and skills . Their virtual R & D collaboration platform , based on the principles of Wikipedia , is another example .
Connecting patients : Severe diseases , such as epilepsy , Crohn ’ s or Parkinson ’ s , tend to be “ silent diseases — sufferers are often
www . ucb . com / 101